Page
%P
-
Article
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon
The inflammatory tumor lymphocytic infiltrates and spontaneous tumor regressions seen in patients with metastatic malignant melanomas suggest a cellular immune involvement. Enhancement of such responses has be...
